Literature DB >> 24234777

Serum SPARC and matrix metalloproteinase-2 and metalloproteinase-9 concentrations after bariatric surgery in obese adults.

Yeon Ji Lee, Yoon-Seok Heo, Hye Soon Park, Seoung Hee Lee, Seul Ki Lee, Yeon Jin Jang.   

Abstract

BACKGROUND: Remodeling of the extracellular matrix (ECM) of adipose tissue is regarded as part of the pathophysiology of obesity. Secreted protein acidic and rich in cysteine (SPARC) was the first ECM protein described in adipose tissue. Matrix metalloproteinases (MMPs) also play a role in ECM remodeling, and MMP-2 and MMP-9 may be associated with abnormal ECM metabolism. Here, we investigated changes in serum SPARC, MMP-2, and MMP-9 concentrations after bariatric surgery in obese adults.
METHODS: We recruited 34 obese patients who were scheduled to undergo bariatric surgery for weight loss. We analyzed changes in serum SPARC, MMP-2, and MMP-9 concentrations before and 9 months after bariatric surgery and any associations between changes in SPARC, MMP-2, and MMP-9 concentrations and obesity-related parameters.
RESULTS: Serum leptin levels significantly decreased, and the serum adiponectin level significantly increased after bariatric surgery. The serum SPARC concentration decreased significantly from 165.0 ± 18.2 to 68.7 ± 6.7 ng/mL (p < 0.001), and the MMP-2 concentration also decreased significantly from 262.2 ± 15.2 to 235.9 ± 10.5 ng/mL (p < 0.001). Changes in the serum SPARC concentration were significantly correlated with HOMA-IR changes, and changes in the serum MMP-9 concentration were found to inversely correlate with serum adiponectin changes.
CONCLUSION: These findings show that significant decreases in serum SPARC and MMP-2 concentrations occur after bariatric surgery. Our results thus suggest that weight loss via bariatric surgery could alter the ECM environment, and that these changes are related to certain metabolic changes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24234777     DOI: 10.1007/s11695-013-1111-z

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  32 in total

Review 1.  Cutaneous wound healing.

Authors:  A J Singer; R A Clark
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

Review 2.  Adipose tissue remodeling in pathophysiology of obesity.

Authors:  Mi-Jeong Lee; Yuanyuan Wu; Susan K Fried
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2010-07       Impact factor: 4.294

3.  Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery.

Authors:  Lars Sjöström; Anna-Karin Lindroos; Markku Peltonen; Jarl Torgerson; Claude Bouchard; Björn Carlsson; Sven Dahlgren; Bo Larsson; Kristina Narbro; Carl David Sjöström; Marianne Sullivan; Hans Wedel
Journal:  N Engl J Med       Date:  2004-12-23       Impact factor: 91.245

4.  The association between circulating secreted protein acidic and rich in cysteine (SPARC) and glycosylated haemoglobin (HbA(1c)) during lifestyle-modified weight reduction intervention in obese male subjects.

Authors:  K Kotani; T Yamada; N Taniguchi
Journal:  J Int Med Res       Date:  2011       Impact factor: 1.671

5.  Matrix metalloproteinase-9 is increased in obese subjects and decreases in response to pioglitazone.

Authors:  Resat Unal; Aiwei Yao-Borengasser; Vijayalakshmi Varma; Neda Rasouli; Craig Labbate; Philip A Kern; Gouri Ranganathan
Journal:  J Clin Endocrinol Metab       Date:  2010-04-14       Impact factor: 5.958

6.  Influence of significant weight loss on serum matrix metalloproteinase (MMP)-7 levels.

Authors:  Claudia Ress; Alexander Tschoner; Christian Ciardi; Markus W Laimer; Julia W Engl; Wolfgang Sturm; Helmut Weiss; Herbert Tilg; Christoph F Ebenbichler; Josef R Patsch; Susanne Kaser
Journal:  Eur Cytokine Netw       Date:  2010-03       Impact factor: 2.737

7.  Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation.

Authors:  A Bouloumié; C Sengenès; G Portolan; J Galitzky; M Lafontan
Journal:  Diabetes       Date:  2001-09       Impact factor: 9.461

8.  Regulation of secreted protein acidic and rich in cysteine during adipose conversion and adipose tissue hyperplasia.

Authors:  Carine Chavey; Jérémie Boucher; Marie-Noëlle Monthouël-Kartmann; E Helene Sage; Isabelle Castan-Laurell; Philippe Valet; Sophie Tartare-Deckert; Emmanuel Van Obberghen
Journal:  Obesity (Silver Spring)       Date:  2006-11       Impact factor: 5.002

9.  Differential effects of various growth factors and cytokines on the syntheses of DNA, type I collagen, laminin, fibronectin, osteonectin/secreted protein, acidic and rich in cysteine (SPARC), and alkaline phosphatase by human pulp cells in culture.

Authors:  H Shiba; T Fujita; N Doi; S Nakamura; K Nakanishi; T Takemoto; T Hino; M Noshiro; T Kawamoto; H Kurihara; Y Kato
Journal:  J Cell Physiol       Date:  1998-02       Impact factor: 6.384

10.  Secreted protein acidic and rich in cysteine deficiency ameliorates renal inflammation and fibrosis in angiotensin hypertension.

Authors:  Matthew J Socha; Marlina Manhiani; Neveen Said; John D Imig; Kouros Motamed
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

View more
  10 in total

Review 1.  Does bariatric surgery improve adipose tissue function?

Authors:  H Frikke-Schmidt; R W O'Rourke; C N Lumeng; D A Sandoval; R J Seeley
Journal:  Obes Rev       Date:  2016-06-08       Impact factor: 9.213

Review 2.  Development of minimally invasive techniques for management of medically-complicated obesity.

Authors:  Farzin Rashti; Ekta Gupta; Suzan Ebrahimi; Timothy R Shope; Timothy R Koch; Christopher J Gostout
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

3.  M1 Polarized Macrophages Persist in Skin of Post-Bariatric Patients after 2 Years.

Authors:  Carlo Amaral; Juliana Rodrigues da Costa; Matheus Oliveira Costa; João Paulo Verbicario; Leonardo Dias; Natale F Gontijo-de-Amorim; Luiz Charles-de-Sá; Christina Maeda Takiya
Journal:  Aesthetic Plast Surg       Date:  2021-11-08       Impact factor: 2.326

4.  The matricellular protein SPARC induces inflammatory interferon-response in macrophages during aging.

Authors:  Seungjin Ryu; Sviatoslav Sidorov; Eric Ravussin; Maxim Artyomov; Akiko Iwasaki; Andrew Wang; Vishwa Deep Dixit
Journal:  Immunity       Date:  2022-08-12       Impact factor: 43.474

Review 5.  The role of SPARC (secreted protein acidic and rich in cysteine) in the pathogenesis of obesity, type 2 diabetes, and non-alcoholic fatty liver disease.

Authors:  Catalina Atorrasagasti; Agostina M Onorato; Guillermo Mazzolini
Journal:  J Physiol Biochem       Date:  2022-08-26       Impact factor: 5.080

Review 6.  Revisiting the matricellular concept.

Authors:  Joanne E Murphy-Ullrich; E Helene Sage
Journal:  Matrix Biol       Date:  2014-07-24       Impact factor: 11.583

7.  Effect of a Very-Low-Calorie Ketogenic Diet on Circulating Myokine Levels Compared with the Effect of Bariatric Surgery or a Low-Calorie Diet in Patients with Obesity.

Authors:  Ignacio Sajoux; Paula M Lorenzo; Diego Gomez-Arbelaez; M Angeles Zulet; Itziar Abete; Ana I Castro; Javier Baltar; María P Portillo; Francisco J Tinahones; J Alfredo Martinez; Ana B Crujeiras; Felipe F Casanueva
Journal:  Nutrients       Date:  2019-10-04       Impact factor: 5.717

8.  Discoidin domain receptor 2 activation of p38 mitogen-activated protein kinase as an important pathway for osteonectin-regulating osteoblast mineralization.

Authors:  Yun-Sen Zhu; Jiang-Nan Zhang; Ting-Ting Mo; Chang Jiang; Ru-Chao Ma; Liang Chen
Journal:  J Orthop Surg Res       Date:  2021-12-07       Impact factor: 2.359

9.  Secreted Protein Acidic and Rich in Cysteine as a Molecular Physiological and Pathological Biomarker.

Authors:  Abdelaziz Ghanemi; Mayumi Yoshioka; Jonny St-Amand
Journal:  Biomolecules       Date:  2021-11-13

Review 10.  Adipokines, Hepatokines and Myokines: Focus on Their Role and Molecular Mechanisms in Adipose Tissue Inflammation.

Authors:  Yakun Ren; Hao Zhao; Chunyan Yin; Xi Lan; Litao Wu; Xiaojuan Du; Helen R Griffiths; Dan Gao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-14       Impact factor: 6.055

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.